VcanBio USA Healthcare Venture Fund, L.P. — Form D
VcanBio USA Healthcare Venture Fund, L.P. of NATICK, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-12-29. The offering totals $50.0M, of which $5.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-12-29
- Form: D
- Accession: 0001144204-17-065705
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $50.0M
- Amount sold: $5.5M
- Remaining: $44.5M
- Minimum investment: $1.0M
- Investors: 1
- Date of first sale: 2017-11-03
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-301938
Issuer
- Name: VcanBio USA Healthcare Venture Fund, L.P.
- CIK: 0001722510
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 21 STRATHMORE ROAD, NATICK, MA, 01760
- Phone: (847) 323-7226
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Walter na Huang | Director | Natick, MA |
| Shijiang na Lu | Director | Natick, MA |
| Yong na Wang | Director | Natick, MA |
| Mingyuan na Wu | Director | Natick, MA |
| n/a na VcanBio Capital Partners, LLC | Promoter | Natick, MA |
More